TBK1 and Oral ulcer: To demonstrate the functional role of IKKε in the macrophage‐mediated transformation, we then used the recently identified inhibitor of IKKε/TBK1, amlexanox, an FDA‐approved drug previously used for the treatment of mouth ulcers (Reilly et al, 2013).